Conclusions & Recommendations
28.5.2 - Refugee/IDP Request Guidelines Subcommittee
Conclusion/Recommendation:
TEC noted with appreciation that Tropical Data’s and partners’ survey methodologies and adaptations have provided adequate data for decisions on allocating Zithromax® and noted the need for continued flexibility in specific contexts. TEC encourages the continued development of simplified approaches to enhance access.
Action:
ITI will continue to work with the ICTC Special Population task team, which includes representatives from Tropical Data and partners, and consider circumstances in which there may be a need for alternative approaches to support the equitable allocation of Zithromax®.
TEC 28
2022
special populations
28.5.3 - Refugee/IDP Request Guidelines Subcommittee
Conclusion/Recommendation:
TEC reiterated its concern that not all populations in need of Zithromax for trachoma have access to it, and looks forward to further information from the ICTC Inventory on at-risk populations for whom current survey approaches might pose a barrier to access.
In order to leave no one behind, national trachoma programs are encouraged to seek these populations and continue using the decision algorithm to support reaching must-reach populations in their specific contexts.
Action:
ITI has worked with national programs to identify at risk populations and submit an application for Zithromax® where appropriate. ITI team members have also supported the ICTC Special Populations task team’s inventory effort in collaboration with ministries of health and their partners.
TEC 28
2022
special populations
28.5.4 - Refugee/IDP Request Guidelines Subcommittee
Conclusion/Recommendation:
As information from the ICTC Inventory becomes available, TEC recommends that ITI work with host endemic countries to ensure that all populations have access to trachoma treatments where needed.
Action:
As additional information from the ICTC Inventory becomes available, ITI will continue to work with national programs to identify at risk populations and submit an application for Zithromax® where appropriate.
TEC 28
2022
special populations
28.6.1 - Serology/Infection
Conclusion/Recommendation:
TEC appreciates the continued efforts in infection and serology and expressed support for WHO to develop standardized protocols and define thresholds for trachoma program decision-making. As additional data become available, TEC requests future presentations from national programs and partners on this topic.
Action:
This will be addressed through presentations at TEC 29 and TEC 30.
TEC 28
2022
alternative indicators (Ct, serology)
27.1.1 - TEC recommendations to the ITI team
Conclusion/Recommendation:
TEC appreciates the extra information that ITI provided on trichiasis surgeries and recommends including past surgical performance (as reported on the TEMF) in the comments column
Action:
This will be addressed for TEC 29.
TEC 27
2022
TEC meeting management
27.1.2 - TEC recommendations to the ITI team
Conclusion/Recommendation:
TEC appreciates the inclusion of regional maps in the TEC book
Action:
ITI will continue to include regional maps in the TEC book.
TEC 27
2022
TEC meeting management
27.1.3 - TEC recommendations to the ITI team
Conclusion/Recommendation:
For future TEC books, TEC requests that ITI:
- Include updates on ongoing surveys and insecurity in the comments (e.g., this was done well in Sudan’s application)
- Continue thinking through the best way to display multiple rounds in one year; there was confusion over interpreting the annual round number column
- For mid-year requests, add “NONE” to TEC Decision Column
Action:
The program team has worked with David Addiss to streamline how ITI represents mid-year requests and multiple rounds in one year in the applications. The new formatting is being used during the TEC 29 application reviews.
TEC 27
2022
TEC meeting management
27.1.4 - TEC recommendations to the ITI team
Conclusion/Recommendation:
TEC requests that SPAs point out the districts on the map they're referring to (by saying the district number and/or using a pointer/cursor on the projected map) when giving their pre-application country overview
Action:
This will be addressed for TEC 29 in both the presentations and on the printed maps (subject to technological constraints).
TEC 27
2022
TEC meeting management
27.1.5 - TEC recommendations to the ITI team
Conclusion/Recommendation:
For future supply chain allocation reports, TEC requests that the SC team separate out Standard vs. Modified approval numbers (where Modified is broken further down into Persistent/Recrudescent and Catch-Up)
Action:
This has been addressed for TEC 29.
TEC 27
2022
TEC meeting management, supply chain
27.2.1 - TEC recommendations to ITI management
Conclusion/Recommendation:
Publically celebrate US government funding to trachoma/NTDs when possible. Liaise with TFGH colleagues who are engaged in the NTD Roundtable to know more.
Action:
This is noted and ITI will continue to engage in such opportunities as they arise.
TEC 27
2022
recommendations for ITI management